Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Saving strategies in this approach focus on purposeful allocations, automatic transfers, and regular budget reviews for consistency.
28,655 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Greece rolls out a four-satellite network that detects fires as small as four meters wide, aiming to cut wildfire los...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
A tiny stock has surged 680% in a year, grabbing headlines and investor attention. This guide breaks down what’s driv...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
A troubling trend is rising where criminals recruit ordinary people through Telegram to intercept high-value deliveri...
iQIYI faces a brutal 2026, but a new strategy focused on IP monetization and international growth could unlock sizabl...
The crypto world pivoted last week as a regulator-approved platform hit a $1 billion weekly volume in perpetual futur...
Per Stirling Capital Management increased its stake in the First Trust Smith Opportunistic Fixed Income ETF (FIXD) by...
P&G leads with broad-based growth and new investments across beauty and global markets, while Colgate-Palmolive leans...
SanDisk stock has surged more than fivefold in 2026 as AI-driven data-center demand reshapes the NAND market. Here’s ...
Applied Materials and KLA posted strong AI-driven results, highlighting a broad vs. focused approach to AI infrastruc...